Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for Ventyx Biosciences, Inc. Common Stock (VTYX).
- Disclosed ownership: 1.9%.
- Date of event: 30 Jun 2025.
BlackRock, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for Ventyx Biosciences, Inc. Common Stock (VTYX)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- VTYX
- Shares outstanding
- 71,104,579 shares
- Disclosed Ownership
- 1,350,987 shares
- Ownership
- 1.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 16 Jul 2025, 19:02:17 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 1.9% ownership in Ventyx Biosciences, Inc. Common Stock (VTYX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 16 Jul 2025, 19:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 1.9% | 1,350,987 | 1,343,394 | 0 | Spencer Fleming | Managing Director |